Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043784 · ClinicalTrials.gov registry record · Phase 3
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
A Phase 3 study of Myocardial Infarction and Myocardial Ischemia, sponsored by Sanofi.
- Completed
- Registry status
- Phase 3
- Development phase
- 8,000
- Enrollment target
- 1
- Study location
NCT00043784: Completed Phase 3 study of Myocardial Infarction and Myocardial Ischemia, sponsored by Sanofi.
NCT00043784 is a Phase 3 study of Myocardial Infarction and Myocardial Ischemia that has completed, run by Sanofi. The registered enrollment target is 8,000 participants, above the 4,557-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00043784, a Phase 3 study of Myocardial Infarction and Myocardial Ischemia, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 8,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients experiencing a mild heart attack will receive one of two medications which thin the blood to discern which is superior.
Conditions Studied
Interventions
- DRUG enoxaparin
Study Locations (1)
North Carolina
- Duke Clinical Research Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2001-08 |
| Phase | Phase 3 |
What the finished NCT00043784 record still lists
NCT00043784 is an interventional study that assigns participants to a tested intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus, above the 4,557-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (76% higher).
The record links to 3 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which enoxaparin is the first listed.
NCT00043784 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00043784 about?
NCT00043784 is a clinical study titled "SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes". Patients experiencing a mild heart attack will receive one of two medications which thin the blood to discern which is superior.
What is the current status of trial NCT00043784?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 8,000 participants. The study started on 2001-08.
What conditions does trial NCT00043784 study?
This clinical trial studies the following conditions: Myocardial Infarction, Myocardial Ischemia, Unstable Angina.
What interventions are being tested in trial NCT00043784?
The interventions under investigation include: enoxaparin (DRUG).
Who is sponsoring clinical trial NCT00043784?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00043784 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00043784's enrollment target sits among peer trials
8,000 6th of 64 higher than 59 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
COMPLETED · Phase 3
-
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
COMPLETED · Phase 3
-
Occluded Artery Trial (OAT)
COMPLETED · Phase 3
-
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
COMPLETED · Phase 3
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Myocardial Ischemia and Transfusion Pilot
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia